<DOC>
	<DOCNO>NCT00687778</DOCNO>
	<brief_summary>F18-FDG widely use PET tracer routine practice oncologic disease image use technology PET-CT . However , FDG-avidity characteristic individual tumor . There various type human malignancy , take FDG access . In case FDG sensitive tracer image . In search tumor PET tracer , C11-Acetate show recently early study potential value image non-FDG-avid tumor . The purpose current study assess role 11C-acetate PET various tumor , often detect 18F-FDG widely assess .</brief_summary>
	<brief_title>11C-Acetate PET/CT Non-FDG-Avid Tumors</brief_title>
	<detailed_description>Recent publication suggest use 11C-acetate another PET tracer tumor imaging . The accumulation 11C-acetate tumor cell relate highly active lipid metabolism cell membrane associate tumor growth . 11C-acetate channeled tricarboxylic acid cycle via acetyl coenzyme A incorporated via phosphatidylcholine cell membrane 's phopholipids . Possible biochemical path acetate incorporation accumulation include ( ) enter Krebs cycle acetyl coenzyme A ( acetyl CoA ) intermediate metabolite , ( b ) esterification form acetyl CoA major precursor ÃŸ-oxidation fatty acid synthesis , ( c ) combine glycine heme synthesis , ( ) citrate cholesterol synthesis . Of possible metabolic pathway , participation free fatty acid ( lipid ) synthesis believe dominant method incorporation tumor . The clinical data role 11C-acetate PET human tumor accumulate . Most clinical study investigate role 11C-acetate PET detection prostate cancer . 11C-acetate PET find valuable detection recurrent prostate cancer , prostate bed , lymph node distant metastasis . The main advantage 11C-acetate show physiological accumulation urinary bladder case 18F -FDG therefore may appropriate detection active pelvic disease . Comparing uptake 18F-FDG 11C-acetate patient lung carcinoma , latter find superior identification bronchiolo-alveolar carcinoma often show intense FDG uptake . In case hepatic mass , well-differentiated HCC tumor detect 11C-acetate poorly differentiate type detect 18F-FDG . These data suggest 11C-acetate PET may valuable detection well-differentiation slow grow tumor may complementary role routinely use 18F-FDG .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Teratoma</mesh_term>
	<mesh_term>Carcinoma , Lobular</mesh_term>
	<criteria>patient newly diagnose tumor , often nonFDG avid show low intensity uptake : Soft tissue sarcoma welldifferentiated thyroid cancer welldifferentiated bronchoalveolar lung cancer indolent lymphomas neuroendocrine tumor GIST uterine malignancy mucinproducing cancer teratoma hepatoma HCC lobular breast carcinoma Patients age 18 patient age 18 year pregnant lactating woman claustrophobic patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>C11-Acetate</keyword>
	<keyword>FDG</keyword>
	<keyword>sarcoma</keyword>
	<keyword>Measurement C11-Acetate uptake tumor often non-FDG avid .</keyword>
	<keyword>Soft tissue sarcoma</keyword>
	<keyword>well-differentiated thyroid cancer</keyword>
	<keyword>well-differentiated bronchoalveolar lung cancer</keyword>
	<keyword>indolent lymphoma , neuroendocrine tumor</keyword>
	<keyword>GIST</keyword>
	<keyword>uterine malignancy</keyword>
	<keyword>mucin-producing cancer</keyword>
	<keyword>teratoma , hepatoma</keyword>
	<keyword>HCC</keyword>
	<keyword>lobular breast carcinoma</keyword>
</DOC>